Richard Moore, MDUniversity of Rochester Targeting HE4 for Checkpoint Immunotherapy of Ovarian Cancer HE4 is a protein that is highly overproduced in ovarian cancer cells and secreted into the bloodstream and serves as a biomarker for the presence of ovarian cancer. However, HE4 is also causally linked to tumorigenesis by promoting enhanced growth, blood vessel […]
Read More